Gamma-Glutamyltransferase Activity in Chronic Dialysis Patients and Renal Transplant Recipients With Hepatitis C Virus Infection

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1319-1323

  Souza, J F ^a   Longui, C A ^a   Miorin, L A ^a   Sens, Y A ^a  

^a Medical Sciences School of Santa Casa of São Paulo   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VIRUS DNA; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHRONIC HEPATITIS; CHRONIC KIDNEY DISEASE; DIALYSIS; DISEASE MARKER; GENOTYPE; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS HEPATITIS;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BRAZIL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; RENAL REPLACEMENT THERAPY;

EID: 45449093988     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.157     Document Type: Article

References (28)

1. Perez R.M., Ferraz M.L.G., Figueiredo M.S., et al. Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol 69 (2003) 489
2. Giordano H.M., Franca A.V., Meirelles L., et al. Chronic liver disease in kidney recipients with hepatitis C virus infection. Clin Transpl 17 (2003) 195
3. Giannini E., Botta F., Fasoli A., et al. Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage. Dig Dis Sci 46 (2001) 524
4. Hwang S.J., Luo J.C., Chu C.W., et al. Hepatic steatosis in hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol 16 (2001) 190
5. Ebeling F., Lappalainen M., Vuoristo M., et al. Factors predicting interferon treatment response in patients with chronic hepatitis C: late viral clearance does not preclude a sustained response. Am J Gastroenterol 96 (2001) 1237
6. Silva I.S.S., Ferraz M.L.C.G., Perez R.M., et al. Role of γ-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 19 (2004) 314
7. Sanger F., Nicklen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74 (1977) 5463
8. Holland P.V., Barrera J.M., Ercilla G., et al. Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol 34 (1996) 2372
9. Khan N., Aswad S., Shidban H., et al. Improved detection of HCV infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J Clin Virol 30 (2004) 175
10. Umlauf F., Gruenewald K., Weiss G., et al. Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 92 (1997) 73
11. Pérsico M., Perrota S., Pérsico E., et al. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years. J Viral Hepat 13 (2006) 290
12. Luzar B., Ferlan-Marolt V., Brinovec V., et al. Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients?. Hepatogastroenterology 50 (2003) 157
13. Hu K.-Q., Lee S.M., Hu S.X., et al. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function. Am J Gastroenterol 100 (2005) 2010
14. Yasuda K., Okuda K., Endo N., et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 109 (1995) 1295
15. Hwang S.J., Luo J.C., Lai C.R., et al. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C. Chung Hua I Hsueh Tsa Chih (Taipei) 63 (2000) 527
16. Boletis J.N., Delladetsima J.K., Makris F., et al. Cholestatic syndromes in renal transplant recipients with HCV infection. Transpl Int 13 (2000) 375
17. Ramalho H.J., Terra E.G., Cartapatti E., et al. Hepatoxicity of azathioprine in renal transplant recipients. Transplant Proc 21 (1989) 1716
18. Perez R.M., Ferreira A.S.P., Silva I.S.S., et al. Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients. Clin Transpl 19 (2005) 763
19. Ruttmann E., Brant L.J., Concin H., and Vorarlberg Health Monitoring and Promotion Program Study Group. γ-Glutamyltransferase as a risk factor for cardiovascular disease mortality. An epidemiological investigation in a cohort of 163, 944 Austrian adults. Circulation 112 (2005) 2130
20. Lee D.S., Evans J.C., Robins S.J., et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 127
21. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 (2004) 535
22. Lee D.H., Gross M.D., and Jacobs Jr. D.R. Cardiovascular risk development in young adults study. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the cardiovascular risk development in young adults (CARDIA) study. Clin Chem 50 (2004) 582
23. De Mutsert R., and Krediet R.T. Malnutrition, inflammation and arteriosclerosis (MIA syndrome) in dialysis patients. Ned Tijdschr Geneeskd 150 (2006) 2023
24. Peng Y.C., Chan C.S., and Chen G.H. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Hepatogastroenterology 46 (1999) 3208
25. Hu K.-Q., Kyulo N., Lim N., et al. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 99 (2004) 860
26. Sens Y.A., Malafronte P., Souza J.F., et al. Cryoglobulinemia in kidney transplant recipients. Transplant Proc 37 (2005) 4273
27. Roccatello D., Fornasieri A., Giachino O., et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49 (2007) 69
28. Mahmoud I.M., Elhabashi A.F., Elsawy E., et al. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 43 (2004) 131